These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21253589)

  • 1. PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis.
    Kulkarni AA; Thatcher TH; Olsen KC; Maggirwar SB; Phipps RP; Sime PJ
    PLoS One; 2011 Jan; 6(1):e15909. PubMed ID: 21253589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts.
    Ferguson HE; Kulkarni A; Lehmann GM; Garcia-Bates TM; Thatcher TH; Huxlin KR; Phipps RP; Sime PJ
    Am J Respir Cell Mol Biol; 2009 Dec; 41(6):722-30. PubMed ID: 19286977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring.
    Kuriyan AE; Lehmann GM; Kulkarni AA; Woeller CF; Feldon SE; Hindman HB; Sime PJ; Huxlin KR; Phipps RP
    Exp Eye Res; 2012 Jan; 94(1):136-45. PubMed ID: 22178289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.
    Wei J; Zhu H; Komura K; Lord G; Tomcik M; Wang W; Doniparthi S; Tamaki Z; Hinchcliff M; Distler JH; Varga J
    Ann Rheum Dis; 2014 Feb; 73(2):446-54. PubMed ID: 23515440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways.
    Ma ZG; Yuan YP; Zhang X; Xu SC; Wang SS; Tang QZ
    EBioMedicine; 2017 Apr; 18():179-187. PubMed ID: 28330809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
    Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
    BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells.
    Guo B; Koya D; Isono M; Sugimoto T; Kashiwagi A; Haneda M
    Diabetes; 2004 Jan; 53(1):200-8. PubMed ID: 14693716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-gamma ligands induce heme oxygenase-1 in lung fibroblasts by a PPARgamma-independent, glutathione-dependent mechanism.
    Ferguson HE; Thatcher TH; Olsen KC; Garcia-Bates TM; Baglole CJ; Kottmann RM; Strong ER; Phipps RP; Sime PJ
    Am J Physiol Lung Cell Mol Physiol; 2009 Nov; 297(5):L912-9. PubMed ID: 19734319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
    Burgess HA; Daugherty LE; Thatcher TH; Lakatos HF; Ray DM; Redonnet M; Phipps RP; Sime PJ
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1146-53. PubMed ID: 15734787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anoctamin-1 is induced by TGF-β and contributes to lung myofibroblast differentiation.
    Reed EB; Orbeta S; Miao BA; Sitikov A; Chen B; Levitan I; Solway J; Mutlu GM; Fang Y; Mongin AA; Dulin NO
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L111-L123. PubMed ID: 38084409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
    Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling.
    Mix KS; Coon CI; Rosen ED; Suh N; Sporn MB; Brinckerhoff CE
    Mol Pharmacol; 2004 Feb; 65(2):309-18. PubMed ID: 14742672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias.
    Konopleva M; Elstner E; McQueen TJ; Tsao T; Sudarikov A; Hu W; Schober WD; Wang RY; Chism D; Kornblau SM; Younes A; Collins SJ; Koeffler HP; Andreeff M
    Mol Cancer Ther; 2004 Oct; 3(10):1249-62. PubMed ID: 15486192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone inhibits TGFβ induced keratocyte transformation to myofibroblast and extracellular matrix production.
    Pan HW; Xu JT; Chen JS
    Mol Biol Rep; 2011 Oct; 38(7):4501-8. PubMed ID: 21127991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative characterization of 15-deoxy-delta(12,14)-prostaglandin J2 in regulating EGFPSmad2 translocation in CHO cells through PPARgamma/TGFbeta/Smad2 pathway.
    Ye F; Sun T; Luo H; Ding H; Chen K; Shen X; Jiang H
    Cell Physiol Biochem; 2006; 18(1-3):143-50. PubMed ID: 16914899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms.
    Conte E; Fruciano M; Fagone E; Gili E; Caraci F; Iemmolo M; Crimi N; Vancheri C
    PLoS One; 2011; 6(10):e24663. PubMed ID: 21984893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.
    Li Y; Wen X; Spataro BC; Hu K; Dai C; Liu Y
    J Am Soc Nephrol; 2006 Jan; 17(1):54-65. PubMed ID: 16291834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.